INDICATIONS:
- Mild to moderate hypertension
- Prevention of cardiovascular events
DOSAGE:
- 1 tablet (40 mg or 80 mg) once daily.
- Max. dose: 80 mg/day.
AVANTAGES:
Effective reduction of LVH (the best indicator of cardiovascular morbidity and mortality)
• Nephroprotective
• Well-tolerated
• Distinctive pharmacological profile:
√ Longer half-life than other ARBs
√ Partial agonist activity at the
PPAR-γ receptor
√ More effective than other ARBs at
improving metabolic syndrome.





Reviews
There are no reviews yet.